Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6808246 | 1.00 | MMP2 (0.61) | MMP2MMP3 | |
| SCHEMBL6268879 | 0.82 | MMP2 (0.65) | MMP2MMP3 | |
| SCHEMBL7758509 | 0.78 | MMP2 (0.71) | MMP2MMP3 | |
| Trifluoroacetic Acid SCHEMBL7762284 | 0.78 | MMP2 (0.60) | MMP2MMP3 | |
| SCHEMBL7762080 | 0.72 | MMP2 (0.54) | MMP2MMP3 | |
| SCHEMBL7026877 | 0.72 | MMP2 (0.49) | MMP2MMP3 | |
| SCHEMBL8649902 | 0.70 | MMP2 (0.50) | MMP2MMP3 | |
| SCHEMBL7763695 | 0.70 | MMP2 (0.73) | MMP2MMP3 | |
| SCHEMBL24252160 | 0.70 | MMP2 (0.64) | MMP2MMP3 | |
| SCHEMBL11989235 | 0.70 | MMP2 (0.64) | MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040229817-A1 | Inhibitors of Hepatitis C virus, compositions and treatments using the same | AGOURON PHARMACEUTICALS, INC. | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229817-A1 | Inhibitors of Hepatitis C virus, compositions and treatments using the same | TIMP3, MMP2, MMP7 | MMP2 2/4885MMP3 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.